SS
Insider
Scott D Sandell
10% ownerScott D Sandell (10% owner) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in Korro Bio, Inc. (KRRO). Across 2 priced purchase filings, the average 21-session return was +8.1% from execution and +2.5% from disclosure (delay-adjusted; derived). The largest single filing was $15.0M of SGP (937,500 sh × $16.00, as filed), executed Feb 9.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+8.1%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+2.5%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$17.3M
shares × price, as filed
Last traded
Mar 10
Filed Mar 12
Median ADV $2.6M across their filed names
Open performance→Volume by month
Buys $17.3M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Not on file
1 filing
Sector per market data · by filing · past 12 months
Most traded names
KRRORecent filings
KRROPURCHASE
Korro Bio, Inc.
View filing →
$2.3M207,100 sh × $11.11
Exec Mar 10
Filed Mar 12 · 8:15 PM ET SGPPURCHASE SpyGlass Pharma, Inc. View filing → $15.0M
937,500 sh × $16.00
Exec Feb 9
Filed Feb 11 · 4:30 PM ET MBXPURCHASE MBX Biosciences, Inc. View filing → $8.0M
500,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET